Ignite Creation Date:
2025-12-24 @ 4:58 PM
Ignite Modification Date:
2025-12-30 @ 3:37 PM
Study NCT ID:
NCT00633750
Status:
COMPLETED
Last Update Posted:
2012-09-05
First Post:
2008-03-11
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Erlotinib in Treating Patients With Breast Cancer That Can Be Removed by Surgery
Sponsor:
Vanderbilt-Ingram Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2002-08
Start Date Type:
None
Primary Completion Date:
2007-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2007-10
Completion Date Type:
ACTUAL
First Submit Date:
2008-03-11
First Submit QC Date:
None
Study First Post Date:
2008-03-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2012-05-01
Results First Submit QC Date:
None
Results First Post Date:
2012-09-05
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2012-08-02
Last Update Post Date:
2012-09-05
Last Update Post Date Type:
ESTIMATED